SWOT Analysis
- S
- W
- O
- T
-
Strength (9)
-
Weakness (4)
See all stocks where promoters decreased their stake. Promoters decreasing their shareholding in a stock is considered negative for the stock.
-
Opportunity (2)
Street Favorite: High Analyst Rating with at least 20% upside
-
Threats (1)
See all stocks where MFs decreased their stake last quarter. MFs decreasing their shareholding in a stock is considered negative for the stock.
- Positive Breakout Second Resistance ( LTP > R2)
- Stock passes majority of CANSLIM Investment criteria
- Good quarterly growth in the recent results
- Companies with Low Debt
- Increasing Revenue every Quarter for the past 4 Quarters
- Book Value per share Improving for last 2 years
- Companies with Zero Promoter Pledge
- Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
- Decrease in Provision in recent results
- Street Favorite: High Analyst Rating with at least 20% upside
- FII / FPI or Institutions increasing their shareholding
Technical Analysis
Moving Averages
- 5 Day 79.9
- 10 Day 80.2
- 12 Day 80.4
- 20 Day 81.1
- 26 Day 81.5
- 50 Day 82.6
- 100 Day 82.3
- 200 Day 81.1
Current Price
- Bullish Moving Averages 7
- Bearish Moving Averages 9
Resistance and support
- First Resistance 80.4
- Second Resistance 81.1
- Third Resistance 81.8
- First Support 78.9
- Second Support 78.2
- Third Support 77.5
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
- CAGR IN 10 YEARS
- 25.76%
- 19.79%
- 11.68%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
||
|---|---|---|---|---|
| Sales | 6,694.69 | 5,374.28 | 4,115.47 |
|
| Operating Profit | 160.45 | 82.71 | -109.54 |
|
| OP Profit Margin | 2.40 | 1.54 | -2.66 |
|
| Interest | 0.00 | 0.00 | 0.00 |
|
| Profit After Tax | 130.78 | 213.52 | 81.85 |
|
| Cash Profit | 166.68 | 238.76 | 113.05 |
|
| EPS | 0.71 | 1.17 | 0.48 |
|
- CAGR IN 10 YEARS
- 34.52%
- 0.0%
- 12.14%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| Equity | 1,847.46 | 1,827.03 | 1,699.54 | 1,510.68 | 1,408.60 |
|
| Reserve Surplus | 1,938.85 | 1,945.99 | 350.92 | -682.92 | -902.96 |
|
| TOT Debts | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
|
| Gross Block | 338.93 | 288.59 | 257.81 | 224.32 | 191.32 |
|
| Capital Work In Progress | 3.36 | 9.35 | 0.51 | 3.73 | 0.52 |
|
| Cash Liquid Investment | 158.66 | 220.35 | 142.82 | 101.86 | 58.81 |
|
| Net Working Capital | -6,305.72 | -4,942.56 | -3,216.39 | -2,343.60 | -1,695.34 |
|
| Current Assets | 1,518.22 | 1,509.83 | 674.82 | 454.89 | 287.44 |
|
| Current Liabilities | 7,823.94 | 6,452.39 | 3,891.21 | 2,798.49 | 1,982.78 |
|
Jun 2026 (CR) |
Mar 2026 (CR) |
Dec 2025 (CR) |
Sep 2025 (CR) |
Jun 2025 (CR) |
||
|---|---|---|---|---|---|---|
| Sales | 2,471.26 | 2,251.06 | 1,611.03 | 1,574.03 | 1,931.75 |
|
| Gross Profit | 183.74 | 180.74 | -87.64 | -35.27 | 97.92 |
|
| Gross Profit Margins | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
|
| Operating Profit | 184.23 | 181.64 | -94.21 | -53.21 | 98.07 |
|
| OP Profit Margin | 7.44 | 8.03 | -5.44 | -2.24 | 5.07 |
|
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
| Profit After Tax | 137.80 | 159.36 | -87.64 | -35.27 | 71.44 |
|
| Cash Profit | 137.80 | 159.36 | -82.39 | -32.84 | 71.44 |
|
| EPS | 0.75 | 0.86 | -0.47 | -0.19 | 0.39 |
|
- CAGR IN 10 YEARS
- 34.52%
- 0.0%
- 12.14%
Mar 2026 (CR) |
Mar 2025 (CR) |
Mar 2024 (CR) |
Mar 2023 (CR) |
Mar 2022 (CR) |
||
|---|---|---|---|---|---|---|
| PE | 99.05 | 66.75 | 0.00 | 0.00 | 0.00 |
|
| P/BV | 3.42 | 3.77 | 0.00 | 0.00 | 0.00 |
|
| MCAP Sales | 1.94 | 2.65 | 0.00 | 0.00 | 0.00 |
|
| Asset Turnover | 1.98 | 1.92 | 2.44 | 3.11 | 2.82 |
|
| EV/EBITDA | 80.29 | 59.98 | 0.00 | 0.00 | 0.00 |
|
| DEBT/EQUITY | 0.07 | 0.25 | 0.50 | 0.37 | 0.23 |
|
| ROE | 2.95 | 5.71 | 3.39 | 0.95 | 0.00 |
|
| ROCE | 3.14 | 5.88 | 3.07 | 0.78 | 0.00 |
|
Quick Results Snapshot
Q1FY27 Quarterly Result Announced for Niva Bupa Health Insurance Company Ltd.
General Insurance company Niva Bupa Health Insurance Company announced Q1FY27 results
Financial Highlights:
- Insurance Revenue for Q1FY27 stood at Rs 2,27,372 lakh, representing a YoY increase of 28.56% from Rs 1,76,861 lakh in Q1FY26 and a QoQ growth of 7.44% from Rs 2,11,618 lakh in Q4FY26.
- Total Investment Income for the quarter Q1FY27 was Rs 19,754 lakh, marking a 21.09% YoY growth compared to Rs 16,314 lakh in Q1FY26 and an increase of 46.46% QoQ from Rs 13,488 lakh in Q4FY26.
- Profit before tax for Q1FY27 was Rs 18,374 lakh, showing a significant YoY growth of 87.64% from Rs 9,792 lakh in Q1FY26 and a marginal QoQ increase of 1.66% from Rs 18,074 lakh in Q4FY26.
- Net profit for Q1FY27 reached Rs 13,780 lakh, registering a 92.89% YoY increase from Rs 7,144 lakh in Q1FY26, while recording a QoQ decline of 13.53% from Rs 15,936 lakh in Q4FY26.
- Total Comprehensive Income for Q1FY27 was Rs 22,919 lakh, as against Rs 13,124 lakh in Q1FY26 and Rs 4,034 lakh in Q4FY26.
- Basic and Diluted earnings per share (EPS) for Q1FY27 was Rs 0.75 and Rs 0.74 respectively, compared to Rs 0.39 and Rs 0.39 in Q1FY26.
- Gross Written Premium (GWP) for Q1FY27 stood at Rs 2,14,996 lakh, up 31.75% YoY from Rs 1,63,190 lakh in Q1FY26.
- The company reported a Net Worth of Rs 3,83,578 lakh as of June 30, 2026.
Business Highlights:
- Fundraising: The Board of Directors approved the issuance of listed, rated, unsecured, subordinated, redeemable, non-convertible debentures of up to Rs 500.00 crore on a private placement basis.
- Regulatory Update: The company has filed an application with IRDAI for forbearance regarding Expenses of Management (EOM) exceeding allowable limits for FY25.
- Solvency and Margins: The Solvency Ratio for Q1FY27 was 2.25, compared to 2.86 in Q1FY26. The Net Insurance Margin improved to 4.44% in Q1FY27 from 0.43% in Q1FY26.
- Claims and Operations: The Claims Ratio for General Insurance and Claims Experience Ratio for Life Insurance business stood at 63.01% in Q1FY27 compared to 66.83% in Q1FY26.
- Segment Performance:
- Health Segment: Reported a total income of Rs 2,47,175 lakh and a segment profit of Rs 12,883 lakh.
- Personal Accident Segment: Reported a total income of Rs 3,583 lakh and a segment profit of Rs 926 lakh.
- Travel Segment: Reported a total income of Rs 317 lakh and a segment loss of Rs 29 lakh.
Stocks Comparison
Table
Chart
Company name |
LTP |
Market cap (Cr) |
Return (1Y %) |
Risk (Std. Dev.) |
PE Ratio |
Financial Year |
|---|---|---|---|---|---|---|
| Niva Bupa Health Insurance Company Ltd | 81.29 | 14,718.05 | -0.97 | 0.06 | 84.62 | Mar 2026 |
| Life Insurance Corporation of India | 398.15 | 515,740.31 | -10.47 | 0.06 | 8.67 | Mar 2026 |
| SBI Life Insurance Company Ltd | 1,765.80 | 173,689.42 | -3.07 | 0.06 | 68.26 | Mar 2026 |
| HDFC Life Insurance Company Ltd | 564.30 | 119,698.79 | -28.08 | 0.05 | 60.74 | Mar 2026 |
| ICICI Lombard General Insurance Company Ltd | 1,503.80 | 72,847.88 | -20.25 | 0.05 | 30.62 | Mar 2026 |
| ICICI Prudential Life Insurance Company Ltd | 497.15 | 71,399.98 | -17.83 | 0.08 | 44.57 | Mar 2026 |
| General Insurance Corporation of India | 347.10 | 61,579.44 | -4.75 | 0.04 | 6.93 | Mar 2026 |
| Star Health & Allied Insurance Company Ltd | 545.20 | 32,200.66 | 21.55 | 0.07 | 38.13 | Mar 2026 |
| New India Assurance Company Ltd | 185.98 | 30,926.37 | -5.09 | 0.14 | 39.79 | Mar 2026 |
| Go Digit General Insurance Ltd | 241.35 | 22,098.01 | -31.43 | 0.07 | 44.86 | Mar 2026 |
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Announcement under Regulation 30 (LODR)-Credit Rating
Sep 17, 2026Intimation of Credit Rating assigned by AM Best
Announcement under Regulation 30 (LODR)-Change in Management
Sep 16, 2026Change in Management of the Company w.e.f September 16 2026.
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Aug 26, 2026Allotment of 411000 Equity Shares
| Ex-Date | Purpose | Notes |
|---|---|---|
| 2026-07-30 | Quarterly Results & Others | |
| 2026-05-08 | Audited Results | |
| 2026-01-29 | Quarterly Results | |
| 2025-11-03 | Quarterly Results | |
| 2025-07-31 | Quarterly Results | |
| 2025-05-07 | Audited Results | |
| 2025-02-04 | Quarterly Results | |
| 2024-11-25 | Quarterly Results |
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
Client name |
Deal Type |
Date |
Action |
Avg. price |
Quantity |
Exchange |
|---|---|---|---|---|---|---|
| Hsbc Global Investment Funds Indian Equity | Block | 2026-06-15 |
Purchase |
83.00 | 2,135,355 | BSE |
| Hsbc Indien | Block | 2026-06-15 |
Purchase |
83.00 | 1,313,743 | BSE |
| Hsbc Indian Equity Mother Fund | Block | 2026-06-15 |
Purchase |
83.00 | 550,902 | BSE |
| Krishnan Ramachandran | Block | 2026-06-15 |
Sell |
83.00 | 4,000,000 | BSE |
| Sbi Mutual Fund | Bulk | 2025-06-02 |
Purchase |
82.00 | 15,172,318 | BSE |
| Dsp Mutual Fund | Bulk | 2025-06-02 |
Purchase |
82.00 | 14,018,374 | BSE |
| M Pallonji And Co Pvt Ltd | Bulk | 2025-06-02 |
Purchase |
83.95 | 13,560,000 | NSE |
| Dsp Mutual Fund | Bulk | 2025-06-02 |
Purchase |
82.00 | 13,462,422 | BSE |
| Dsp Mutual Fund | Bulk | 2025-06-02 |
Purchase |
82.00 | 12,392,956 | BSE |
| Irage Broking Services Llp | Bulk | 2025-06-02 |
Purchase |
83.36 | 10,852,566 | BSE |
| Patronus Tradetech Llp | Bulk | 2025-06-02 |
Purchase |
82.99 | 10,166,931 | BSE |
| Dsp Mutual Fund | Bulk | 2025-06-02 |
Purchase |
82.00 | 9,769,825 | BSE |
| Share India Securities Limited | Bulk | 2025-06-02 |
Purchase |
82.64 | 9,174,947 | BSE |
| Share India Securities Limited | Bulk | 2025-06-02 |
Purchase |
83.05 | 4,745,711 | NSE |
| Irage Broking Services Llp | Bulk | 2025-06-02 |
Purchase |
83.04 | 3,207,665 | NSE |
| Patronus Tradetech Llp | Bulk | 2025-06-02 |
Purchase |
82.99 | 436,918 | NSE |
| Fettle Tone Llp | Bulk | 2025-06-02 |
Sell |
82.11 | 91,463,415 | BSE |
| Fettle Tone Llp | Bulk | 2025-06-02 |
Sell |
82.76 | 81,463,414 | BSE |
| Share India Securities Limited | Bulk | 2025-06-02 |
Sell |
82.91 | 11,196,723 | NSE |
| Irage Broking Services Llp | Bulk | 2025-06-02 |
Sell |
83.51 | 10,919,157 | NSE |
| Patronus Tradetech Llp | Bulk | 2025-06-02 |
Sell |
83.91 | 10,184,741 | NSE |
| Krishnan Ramachandran | Bulk | 2025-06-02 |
Sell |
82.30 | 10,000,000 | BSE |
| Irage Broking Services Llp | Bulk | 2025-06-02 |
Sell |
83.13 | 3,141,074 | BSE |
| Share India Securities Limited | Bulk | 2025-06-02 |
Sell |
82.50 | 2,723,935 | BSE |
| Patronus Tradetech Llp | Bulk | 2025-06-02 |
Sell |
83.08 | 419,108 | BSE |
Client name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Avg. Price |
Regulation (Insider/SAST) |
Mode |
|---|---|---|---|---|---|---|---|---|
| Aranda Investments Pte Ltd | Other |
Acquisition |
2026-02-18 | 70,000 | 92,370,975 | SAST 29(1) | Market | |
| Fettle Tone Llp | Other |
Disposal |
2025-06-27 | 172,926,829 | 146,202,091 | SAST 29(2) | Market | |
| Vikas Gupta | Designated Person |
Disposal |
2024-12-30 | 40,000 | 187,991 | 80.63 | Insider Trading | Market Sale |
| Krishnan Ramachandran | KMP |
Disposal |
2024-12-16 | 5,000,000 | 10,775,040 | 83.54 | Insider Trading | Market Sale |
| Padmesh Nair | Designated Person |
Disposal |
2024-12-13 | 150,000 | 1,953,533 | 99.80 | Insider Trading | Market Sale |
| Bhabatosh Mishra | Designated Person |
Disposal |
2024-12-13 | 25,000 | 3,113,783 | 91.50 | Insider Trading | Market Sale |
| Shilpa Verma | Designated Person |
Disposal |
2024-12-10 | 20,000 | 35,000 | 102.70 | Insider Trading | Market Sale |
| Partha Banerjee | Designated Person |
Revoke |
2024-12-10 | 200,000 | 209,137 | 92.00 | Insider Trading | Pledge Released |
| Suraj Mishra | Designated Person |
Disposal |
2024-12-10 | 102,000 | 2,600,000 | 104.96 | Insider Trading | Market Sale |
| Vikas Gupta | Designated Person |
Disposal |
2024-12-10 | 30,000 | 227,991 | 100.00 | Insider Trading | Market Sale |
| Partha Banerjee | Designated Person |
Revoke |
2024-12-10 | 200,000 | 9,137 | 98.72 | Insider Trading | Pledge Released |
| Vikas Vikram | Designated Person |
Disposal |
2024-12-10 | 70,000 | 0 | 96.36 | Insider Trading | Market Sale |
About Niva Bupa Health Insurance Company Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Niva Bupa Health Insurance Company Limited was initially incorporated as `Max Bupa Health Insurance Limited` at New Delhi, Delhi as a Public Limited Company dated September 5, 2008 and granted its Certificate for Commencement of Business on December 23, 2008 by the Deputy Registrar of Companies, NCT of Delhi and Haryana. Thereafter, Company changed its name to `Max Bupa Health Insurance Company Limited`, dated July 30, 2009 and again to `Niva Bupa Health Insurance Company Limited` pursuant to a fresh Certificate of Incorporation dated July 5, 2021 issued by the Registrar of Companies, Delhi. The Company is a standalone health insurer (SAHI) strategically focused on the retail health market. The Company underwrites primarily Health Insurance business which includes Personal accident, Critical illness and Travel. Bupa Singapore Holdings Pte Ltd. and Bupa Investments Overseas Limited are the Promoters of the Company and holds 55% shareholding. The Company incorporated in September 2008 as a joint venture between Max India Limited and Bupa Singapore Holdings Pte. Ltd. The Company obtained regulatory approval to undertake Health Insurance business on 15th February 2010 from Insurance Regulatory and Development Authority of India (IRDAI and started selling Policies in March 2010. Bupa Singapore Holdings Pte. Ltd. increased its shareholding in the Company from 26% to 49% in July 2016. Through acquisition of Equity Shares of the Company from Max India Limited and Bupa Singapore Pte. Ltd., Fettle Tone LLP became a shareholder in the Company in 2019. The Company became a subsidiary of Bupa Singapore Holdings Pte. Ltd. by acquiring 366,381,439 Equity Shares of the Company from Fettle Tone LLP in 2024. The Company launched the initial public offer of 297,297,296 equity shares of face value of Rs 10 each, by raising funds aggregating to Rs 2200 Cr, comprising a fresh issue of 108,108,108 equity shares aggregating to Rs 800 Cr and offer for sale of 189,189,188 equity shares aggregating to Rs 1400 Cr in November, 2024. The Company`s Retail Health Market Share rose to 9.4% up from 9.1% in FY 2025. It launched Rise, new health insurance product with innovative features like Flexi-pay, Return, Smart Cash & Unlimited Digital Consultations in 2025. The Company further expanded the business with the launch of ReAssure 3.0- India`s health insurance plan in FY 2026.
Niva Bupa Health Insurance Company share price as on 21 Sep 2026 is Rs. 81.29. Over the past 6 months, the Niva Bupa Health Insurance Company share price has increased by 13.58% and in the last one year, it has decreased by 0.97%. The 52-week low for Niva Bupa Health Insurance Company share price was Rs. 67.5 and 52-week high was Rs. 91.4.
C-98 1st Flr Lajpat Nagar, Part 1 South Delhi, New Delhi, New Delhi, 110024
Tel No. +91 124 635 4900
Email investor:nivabupa.com
Non Executive Director / Nominee
Company Sec. & Compli. Officer
Independent Non Exe. Director
Non Executive Director
EXE. Director & Deputy CEO
Non Executive Director
Managing Director & CEO
Independent Director
Non Executive Director
Chairman & Independent Directo
Independent Non Exe. Director
Executive Director / Whole Time Director / CFO
544286
NIVABUPA
INE995S01015
Aug
Niva Bupa Health Insurance Company Ltd FAQs
You can buy Niva Bupa Health Insurance Company Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Niva Bupa Health Insurance Company Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Sep 21, 2026 10:59 AM the closing price of Niva Bupa Health Insurance Company Ltd was Rs.81.29.
The latest PE ratio of Niva Bupa Health Insurance Company Ltd as of Sep 21, 2026 10:59 AM is 84.62
The latest PB ratio of Niva Bupa Health Insurance Company Ltd as of Sep 21, 2026 10:59 AM is 3.89
The 52-week high of Niva Bupa Health Insurance Company Ltd share price is Rs. 91.40 while the 52-week low is Rs. 67.50
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 21, 2026 10:59 AM, the market cap of Niva Bupa Health Insurance Company Ltd stood at Rs. 15,032.42 Cr.
